PepEvolution
HomeRankingsGHK-Cu + BPC-157
RecoveryPreliminary grade

GHK-Cu + BPC-157

Healing and skin-remodeling blend combining a copper tripeptide with BPC-157, clean components, no blend trial.

Verdict, C · Emerging / Mixed

Two clean, complementary compounds with individually solid evidence, but no blend data and less common sourcing than the BPC/TB stack. A viable option for recovery with a cosmetic/skin co-aim; verify both components by COA.

Overview

The GHK-Cu + BPC-157 blend combines a copper tripeptide with broad gene-regulation and tissue-remodeling activity (GHK-Cu) with the best-sourced recovery peptide in the catalog (BPC-157). The theoretical rationale is complementary: GHK-Cu drives skin and connective-tissue remodeling while BPC-157 supports vascular and anti-inflammatory healing. Both components have individually favorable safety profiles. No fixed-blend RCT exists; evidence is component-derived.

PepScore Breakdown, the four axes

Evidence

35% weight
38/100

How strong is the published human science?

Human data depth12/40
Regulatory & registry status8/30
Reproducibility & consistency11/20
Mechanism characterized in humans7/10

Sourcing & COA

30% weightOur moat
64/100

Can a buyer obtain an independently-verified, high-purity version?, our proprietary layer.

Independent + portal-verifiable testing22/35
Method transparency (HPLC + MS + endotoxin/sterility, methods stated)16/25
Lot-matched + recent16/25
Independent corroboration10/15

Safety & Risk

25% weight
72/100

What is the real-world harm potential?

Documented AEs / toxicity30/40
Contraindication breadth18/25
Regulatory warnings12/20
Therapeutic index / margin12/15

Practicality

10% weight
70/100

How easy is it to actually run a verified version?

Verified-source availability24/35
Cost / value per cycle16/25
Reconstitution & administration20/25
Storage & stability10/15

Sources & Citations

Every claim cites a primary source. Citations are machine-audited against NCBI, see methodology.

Want a clinical path?

Talk to a licensed provider about GHK-Cu + BPC-157 and whether it's appropriate for your situation.

Talk to a Provider ↗

Telehealth. Not medical advice, for educational purposes.

PepScore58/100 · C
Last gradedJune 28, 2026
Next re-grade triggerA blend-level human trial would be the primary evidence mover; broader vendor availability would lift Practicality.

Get the PepEvolution Dispatch

Monthly COA findings, vendor changes, and new grades. Research/educational only, no spam.

Educational only, not medical advice. PepScore is an educational research grade, not a prescription or dosing recommendation. Some vendor links are affiliate links, this never affects grades. Consult a licensed healthcare provider before using any compound.